Position in INBX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,719,009
+$1,421,680 QoQ
Shares Held
303,103
-25.3% QoQ
Ownership
2.06%
of shares outstanding
% of Portfolio
1.53%
of 13F equity value
Holder Rank
#15
of 162 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INBX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sofinnova Investments, Inc. holds $1,182,454,857 across 43 Biotechnology names. INBX ranks #19 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VERA |
Vera Therapeutics, Inc.
|
2,793,987 | $119,889,982 | |
| 2 | GMAB |
Genmab A/S
|
4,045,215 | $111,122,056 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
365,341 | $88,036,220 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
1,904,408 | $79,356,681 | |
| 5 | SPTX |
Seaport Therapeutics, Inc.
|
3,564,871 | $77,428,998 | |
| 6 | AVBP |
ArriVent BioPharma, Inc.
|
1,696,752 | $58,945,164 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,717,505 | $57,347,491 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
408,027 | $45,303,237 |
All Filings in INBX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,719,009 | 303,103 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $27,297,329 | 406,029 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,917,903 | 454,657 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,822,298 | 440,092 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,112,835 | 708,678 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,763,844 | 697,916 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,118,726 | 527,190 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,394,824 | 536,068 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,565,173 | 463,315 | Shares | Sole | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||